Cargando…
The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones
Aspartimide (Asi) formation is a notorious side reaction in peptide synthesis that is well characterized and described in literature. In this context, we observed significant amounts of chain termination in Fmoc‐SPPS while synthesizing the N‐terminal Xaa‐Asp‐Yaa motif. This termination was caused by...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772008/ https://www.ncbi.nlm.nih.gov/pubmed/31309675 http://dx.doi.org/10.1002/psc.3193 |
_version_ | 1783455814705479680 |
---|---|
author | Samson, Daniel Rentsch, Daniel Minuth, Marco Meier, Thomas Loidl, Günther |
author_facet | Samson, Daniel Rentsch, Daniel Minuth, Marco Meier, Thomas Loidl, Günther |
author_sort | Samson, Daniel |
collection | PubMed |
description | Aspartimide (Asi) formation is a notorious side reaction in peptide synthesis that is well characterized and described in literature. In this context, we observed significant amounts of chain termination in Fmoc‐SPPS while synthesizing the N‐terminal Xaa‐Asp‐Yaa motif. This termination was caused by the formation of piperazine‐2,5‐diones. We investigated this side reaction using a linear model peptide and independently synthesizing its piperazine‐2,5‐dione derivative. Nuclear magnetic resonance (NMR) data of the side product present in the crude linear peptide proves that exclusively the six‐membered ring is formed whereas the theoretically conceivable seven‐membered 1,4‐diazepine‐2,5‐dione is not found. We propose a mechanism where nucleophilic attack of the N‐terminal amino function takes place at the α‐carbon of the carbonyl group of the corresponding Asi intermediate. In addition, we systematically investigated the impact of (a) different adjacent amino acid residues, (b) backbone protection, and (c) side chain protection of flanking amino acids. The side reaction is directly related to the Asi intermediate. Hence, hindering or avoiding Asi formation reduces or completely suppresses this side reaction. |
format | Online Article Text |
id | pubmed-6772008 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67720082019-10-07 The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones Samson, Daniel Rentsch, Daniel Minuth, Marco Meier, Thomas Loidl, Günther J Pept Sci Research Articles Aspartimide (Asi) formation is a notorious side reaction in peptide synthesis that is well characterized and described in literature. In this context, we observed significant amounts of chain termination in Fmoc‐SPPS while synthesizing the N‐terminal Xaa‐Asp‐Yaa motif. This termination was caused by the formation of piperazine‐2,5‐diones. We investigated this side reaction using a linear model peptide and independently synthesizing its piperazine‐2,5‐dione derivative. Nuclear magnetic resonance (NMR) data of the side product present in the crude linear peptide proves that exclusively the six‐membered ring is formed whereas the theoretically conceivable seven‐membered 1,4‐diazepine‐2,5‐dione is not found. We propose a mechanism where nucleophilic attack of the N‐terminal amino function takes place at the α‐carbon of the carbonyl group of the corresponding Asi intermediate. In addition, we systematically investigated the impact of (a) different adjacent amino acid residues, (b) backbone protection, and (c) side chain protection of flanking amino acids. The side reaction is directly related to the Asi intermediate. Hence, hindering or avoiding Asi formation reduces or completely suppresses this side reaction. John Wiley and Sons Inc. 2019-07-15 2019-07 /pmc/articles/PMC6772008/ /pubmed/31309675 http://dx.doi.org/10.1002/psc.3193 Text en © 2019 The Authors Journal of Peptide Science published by European Peptide Society and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Samson, Daniel Rentsch, Daniel Minuth, Marco Meier, Thomas Loidl, Günther The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones |
title | The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones |
title_full | The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones |
title_fullStr | The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones |
title_full_unstemmed | The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones |
title_short | The aspartimide problem persists: Fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (Fmoc‐SPPS) chain termination due to formation of N‐terminal piperazine‐2,5‐diones |
title_sort | aspartimide problem persists: fluorenylmethyloxycarbonyl‐solid‐phase peptide synthesis (fmoc‐spps) chain termination due to formation of n‐terminal piperazine‐2,5‐diones |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772008/ https://www.ncbi.nlm.nih.gov/pubmed/31309675 http://dx.doi.org/10.1002/psc.3193 |
work_keys_str_mv | AT samsondaniel theaspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT rentschdaniel theaspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT minuthmarco theaspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT meierthomas theaspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT loidlgunther theaspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT samsondaniel aspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT rentschdaniel aspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT minuthmarco aspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT meierthomas aspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones AT loidlgunther aspartimideproblempersistsfluorenylmethyloxycarbonylsolidphasepeptidesynthesisfmocsppschainterminationduetoformationofnterminalpiperazine25diones |